Curing blindness by repairing corneas with invisible films

August 15, 2016, Fresh Science
Credit: Fresh Science

A patented treatment could restore eyesight for millions of sufferers of corneal disease.

The University of Melbourne–led team of researchers have grown on a layer of film that can be implanted in the eye to help the cornea heal itself. They have successfully restored vision in animal trials and are aiming to move to human trials next year.

Victor Fortmann's vision in one eye failed following a condition called bullous keratopathy. Two donated cornea transplants restored his sight for a period, but he now needs a third to restore his vision in that eye.

Over 2000 corneal transplants are conducted in Australia each year. But globally there's a shortage of donated corneas, and the resulting loss in vision affects about 10 million people worldwide.

"We believe that our new treatment performs better than a donated cornea, and we hope to eventually use the patient's own cells, reducing the risk of rejection," says Berkay Ozcelik who developed the film working at the University of Melbourne.

"Further trials are required but we hope to see the treatment trialled in patients next year," he says.

The cornea is the transparent layer at the front of the eye. To remain healthy and transparent, the cornea must remain thin. A layer of specialised cells () on its inner surface maintain the cornea's moistness by 'pumping' water out of it.

However, trauma, disease and aging can reduce the numbers of these cells, eventually causing the cornea to become swollen and cloudy, leading to vision deterioration and blindness.

The cells cannot regenerate or repair themselves. The only treatment available requires donor corneas to be transplanted into the patient's eyes. But there's a worldwide shortage of donor corneas. The transplant process damages some corneal endothelial cells, and the may still be rejected by the patient's immune system.

Berkay and his colleagues grew corneal cells on a specially developed synthetic film that could then be implanted into a patient's eye.

"The hydrogel film we have developed allows us to grow a layer of corneal cells in the laboratory," says Berkay. "Then, we can implant that film on the of a patient's cornea, within the eye, via a very small incision." Once in place the new cells restore the cornea's vital water-pumping activity, so that the cornea once more becomes transparent.

Thinner than a human hair (50µm), the hydrogel film is perfectly transparent when implanted, and allows the flow of water between the cornea and the interior of the eye. The film completely biodegrades within two months and causes no adverse immune reactions.

Berkay developed the synthetic film used to culture new corneal cells at the Polymer Science Group (the University of Melbourne), working with the Centre for Eye Research Australia. Berkay is now working in a similar field at CSIRO and is still active with the corneal film project as an Honorary Post-doctoral Fellow at the University.

Explore further: Corneal transplants, men and women don't see eye to eye

Related Stories

Corneal transplants, men and women don't see eye to eye

July 14, 2016
A new study of patients undergoing corneal transplants indicates that subtle differences between men and women may lead to poorer outcomes for a woman who has received a cornea from a male donor.

Substances found in cornea activate healing of blinding scar tissue

December 18, 2015
Doctoral student Marta Słoniecka at the Department of Integrative Medical Biology has found that the neuropeptide substance P and the neurotransmitter acetylcholine activate and enhance healing of the cornea. The two substances ...

Vision restored in rabbits following stem cell transplantation

March 9, 2016
Scientists have demonstrated a method for generating several key types of eye tissue from human stem cells in a way that mirrors whole eye development.

Simple procedure could improve treatment for common eye disease

July 13, 2016
A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea ...

First corneal stem cell transplant conducted in Ireland

June 10, 2016
On Tuesday 7th June 2016, the first Limbal Stem Cell transplant in Ireland was performed by Mr. William Power, Consultant Ophthalmologist at the Royal Victoria Eye and Ear Hospital (RVEEH) in Dublin.   While this technique ...

Recommended for you

Researchers report vision-based neurotransmitter events for the first time

November 27, 2018
How does vision work, and what happens in the brain during the process? As simple as this question may sound, it has yet to be scientifically clarified. Dr. Valentin Riedl of the Technical University of Munich (TUM) and his ...

Minimally invasive retinal detachment has better outcomes, clinical trial findings

November 26, 2018
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital ...

Scientists combine technologies to view the retina in unprecedented detail

November 14, 2018
By combining two imaging modalities—adaptive optics and angiography—investigators at the National Eye Institute (NEI) can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina. Resolving ...

Eyepatch with dissolvable needles used to treat eye disease

November 12, 2018
A team of researchers affiliated with several institutions in Singapore has developed an eyepatch with dissolvable needles for use in treating eye diseases. In their paper published in the journal Nature Communications, the ...

Calcifications in the eye increase risk for progression to advanced AMD by more than six times

November 8, 2018
Calcified nodules in the retina are associated with progression to late stages of age-related macular degeneration (AMD). Experts from Queen's University Belfast, working in partnership with the University of Alabama of Birmingham ...

Traditional glaucoma test can miss severity of disease

November 8, 2018
The most common tests for glaucoma can underestimate the severity of the condition by not detecting the presence of central vision loss, according to a new Columbia University study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.